Literature DB >> 15282209

Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.

Raul Perez-Olle1, Sidonie T Jones, Ronald K H Liem.   

Abstract

Mutations in the neurofilament light (NFL) gene cause Charcot-Marie-Tooth (CMT) disease. There is a wide range of clinical presentations in CMT patients harboring NFL mutations, with patients classified as CMT2E or CMT1F. In this study, we analyzed the effects of five NFL mutations on the assembly and intracellular distribution of intermediate filaments (IFs), and compared the results with those obtained previously for other NFL mutations. Although all NFL mutants affected the formation of IF networks, our data show differential effects on the assembly of IFs depending on the exact nature of the mutation. Defective transport of the mutant NFL subunits was observed for all the CMT-linked NFL mutations, but the characteristics of this defect also depended on the specific mutation. These results show that defects in the assembly and transport of NFs are common to all NFL mutants studied thus far, but the exact nature of the defect appears to be correlated with each mutant genotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282209     DOI: 10.1093/hmg/ddh236

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.

Authors:  Hailian Shen; Devin M Barry; Jeffrey M Dale; Virginia B Garcia; Nigel A Calcutt; Michael L Garcia
Journal:  Hum Mol Genet       Date:  2011-04-14       Impact factor: 6.150

Review 2.  How to assess the pathogenicity of mutations in Charcot-Marie-Tooth disease and other diseases?

Authors:  Andrzej Kochański
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 3.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.

Authors:  Chiara Pisciotta; Yunhong Bai; Kathryn M Brennan; Xingyao Wu; Tiffany Grider; Shawna Feely; Suola Wang; Steven Moore; Carly Siskind; Michael Gonzalez; Stephan Zuchner; Michael E Shy
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

5.  Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.

Authors:  Mario A Saporta; Vu Dang; Dmitri Volfson; Bende Zou; Xinmin Simon Xie; Adijat Adebola; Ronald K Liem; Michael Shy; John T Dimos
Journal:  Exp Neurol       Date:  2014-10-30       Impact factor: 5.330

6.  Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.

Authors:  Adijat A Adebola; Theo Di Castri; Chui-Zhen He; Laura A Salvatierra; Jian Zhao; Kristy Brown; Chyuan-Sheng Lin; Howard J Worman; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

Review 7.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 8.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

9.  Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.

Authors:  Natalia Ninkina; Owen Peters; Steven Millership; Hatem Salem; Herman van der Putten; Vladimir L Buchman
Journal:  Hum Mol Genet       Date:  2009-02-26       Impact factor: 6.150

10.  Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential.

Authors:  Markus Uhrig; Peter Brechlin; Olaf Jahn; Yuri Knyazev; Annette Weninger; Laura Busia; Kamran Honarnejad; Markus Otto; Tobias Hartmann
Journal:  BMC Med       Date:  2008-12-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.